Drug Patent Expirations in August 2012

Drug Patent Expirations for August 2012

Tradename Applicant Generic Name Patent Number Patent Expiration
PHOTOFRIN Pinnacle Biolgs porfimer sodium 5438071 Aug 1, 2012
SINGULAIR Merck montelukast sodium 5565473*PED Aug 3, 2012
SUSTIVA Bristol Myers Squibb efavirenz 5811423 Aug 7, 2012
ATRIPLA Gilead efavirenz; emtricitabine; tenofovir disoproxil fumarate 5811423 Aug 7, 2012
CARDIZEM CD Valeant Intl diltiazem hydrochloride 5439689 Aug 8, 2012
CHLORAPREP ONE-STEP FREPP Carefusion chlorhexidine gluconate; isopropyl alcohol D396911 Aug 11, 2012
EXELON Novartis rivastigmine 4948807 Aug 14, 2012
EXELON Novartis rivastigmine tartrate 4948807 Aug 14, 2012
VITRAVENE PRESERVATIVE FREE Novartis fomivirsen sodium 5595978 Aug 15, 2012
VITRAVENE PRESERVATIVE FREE Novartis fomivirsen sodium 5442049 Aug 15, 2012
ALOCRIL Allergan nedocromil sodium RE38628 Aug 22, 2012
ACUTECT Cis Bio Intl Sa technetium tc-99m apcitide 5443815 Aug 22, 2012
*Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatch database for complete details.

Subscribers have access to valuable datasets, including:

  • Clinical trial information
  • International patent families
  • International patent priority and PCT information
  • Patent maintenance
  • Full-text patent downloads
  • Sales data (top 200 drugs)
  • Paragraph IV challenges
  • Tentative approvals
  • Dynamic search capabilities with data export
  • More…
See the Database Preview and Plan Comparison.

Contact Us with any questions.

Comments are closed.

Get email updates

Enter your email address to subscribe to this blog and receive notifications of new posts by email.